Human peripheral blood leukocytes (hPBL) are a rich source of natural
leukocyte interferon (IFN-alpha) when treated with Sendai virus, Senda
i virus treatment of hPBL will also result in significant production o
f several chemokines and cytokines such as macrophage inflammatory pro
tein-la (MIP-1 alpha), MIP-1 beta, RANTES, tumor necrosis factor-alpha
(TNF-alpha), interleukin-6 (IL-6), and IL-8, in a time-dependent way,
A significant amount of MCP-1 is constitutively produced in overnight
culture of leukocytes, The most abundant cytokine is IFN-alpha, which
is induced to its maximum level approximately 11-15 h after addition
of Sendai virus, The amount of IFN-alpha induced at 15 h after Sendai
virus treatment is more than 16-fold higher than those of MIP-1 alpha,
MIP-1 beta, and RANTES, IFN-alpha is also induced more than 60-fold h
igher than TNF-alpha and IL-8, The amount of IL-6 induced is approxima
tely 400-fold less than IFN-alpha, Limited amounts of other cytokines
such as IL-1 alpha, IL-1 beta, macrophage colony-stimulating factor, T
NF-beta, and IFN-gamma are also induced in Sendai virus-treated hPBL,
No measurable amount of granulocyte-macrophage colony-stimulating fact
or, granulocyte colony-stimulating factor, leukemia inhibitory factor,
IL-2, IL-3, IL-4, IL-5, IL-7, IL-10, IL-11, or IL-12 was induced in t
he supernatant of Sendai virus-treated hPBL.